ATNM
Actinium Pharmaceuticals
$1.53
+$0.15 (+10.87%)Oct 29, 2026
Key metrics
The numbers that frame ATNM today
- Market cap
- $48.11M
- P/E (TTM)
- 4.3
- Gross margin
- 100%
- EV / Sales
- 0.4
- ROIC
- -371.1%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $0.74
- 52wk High
- $1.72
Growth
Revenue and earnings trend for ATNM
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about ATNM
Is Actinium Pharmaceuticals a good buy?
Yes. Actinium Pharmaceuticals has excellent quality and mixed momentum. Taken together, the setup leans positive. Growth looks excellent, which supports the long-term business case. We think Actinium Pharmaceuticals is selling at a fair price.
What is the market capitalization of ATNM?
Actinium Pharmaceuticals's market capitalization is $48.11M.
What is the P/E (TTM) ratio for ATNM stock?
Actinium Pharmaceuticals's P/E (TTM) ratio is 4.3, based on trailing earnings.
What is the 52-week high for ATNM stock?
The 52-week high for Actinium Pharmaceuticals is $1.72. The current close of $1.53 is 11% below that high.
What is the 52-week low for ATNM stock?
The 52-week low for Actinium Pharmaceuticals is $0.74. The current close of $1.53 is 108.2% above that low.
Does ATNM stock pay dividends?
Actinium Pharmaceuticals does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for ATNM?
Actinium Pharmaceuticals's Debt / Equity ratio is 0.04.